Severe bleeding diathesis associated with moxalactam administration.

S Meisel

doi:10.1177/106002808401800909

Home/Archive/PubMed

PubMed · 6479021

Severe bleeding diathesis associated with moxalactam administration.

S Meisel

View original source ↗Export metadata ↓

Abstract

A case is presented of a severe bleeding diathesis associated with moxalactam administration that was confirmed on rechallenge. Potential mechanisms of action and recommendations for patient monitoring are discussed.

Explore related subjects

Hemorrhagic Disorders Humans Male Middle Aged Moxalactam Vitamin K Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

S Meisel. 1984. Severe bleeding diathesis associated with moxalactam administration.. https://doi.org/10.1177/106002808401800909

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Dependant factors.

Explore the source record for details and available documents.

Hemorrhagic Disorders↗

PubMed2004

Difficulty breathing. Late onset vitamin K deficiency bleeding.

Explore the source record for details and available documents.

Hemorrhagic Disorders↗

PubMed2003

Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation.

A 49-year-old male with alcoholic cirrhosis suffered several spontaneous, life-threatening, deep muscle bleeding episodes. Laboratory evaluation indicated excessive fibrinolysis with low plasminogen, low alpha2-antiplasmin, undetectable plasminogen activator inhibitor type 1 (PAI-1) activity, high tissue plasminogen activator (t-PA) activity and high t-PA antigen. Treatment with oral anti-fibrinolytic agents prevented further bleeding episodes. Decompensated cirrhosis eventually necessitated orthotopic liver transplantation. Post-operatively, the patient did not require oral anti-fibrinolytic agents, and there were no significant bleeding events. Circulating PAI-1 activity, t-PA activity and antigen normalized by 3 months post transplant. In short, the profound bleeding diathesis, as well as the imbalance in t-PA and PAI-1 levels, corrected after liver transplantation. Recognition of such patients is important, because the bleeding diathesis is an indication rather than a contraindication for orthotopic liver transplantation.

Hemorrhagic Disorders↗